CODX vs KMX · rev $3.9M vs P/E 19, rev $26.35B
Co-Diagnostics, Inc. Common Stock (CODX) versus CarMax Inc (KMX) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
CarMax Inc (KMX) is a auto & truck dealerships company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported KMX revenue for 2025-02-28 was $26.35B. Net income was $500.6M. Revenue was down 0.7% from 2024-02-29 to 2025-02-28. KMX currently screens at market cap $10.26B and trailing P/E 18.9.
CODX currently screens at market cap $31.4M. KMX currently screens at market cap $10.26B and trailing P/E 18.9.
Not investment advice. Open the CODX and KMX stock pages for the full models.
Not investment advice.